UMLS - Terms starting with ‘R’

	Medical glossary.
	MEDINDEX.AM UMLS About Catalog. Medical sites. UMLS.Semantic Types. Feedback

%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z a c d e g h i

T T T( T, T- T0 T1 T2 T3 T4 T9 TA TB TC TD TE TF TG TH TI TJ TK TL TM TN TO TP TQ TR TS TT TU TV TW TX TY TZ

TR TR TRA TRE TRF TRH TRI TRK TRN TRO TRP TRU TRY

selected terms: 3,280

1 2 3 4 .. 33 Next >>

page 1 of 33

1,1'-(2,2,2-Trichloroethylidene)-bis[4-chlorobenzene]: [insecticide that came into prominence during and after World War II; for a time it proved very effective, but insect populations rapidly developed tolerance for it, hence much of its original effectiveness has been lost; general usage is now widely discouraged because of the toxicity that results from the environmental persistence of this agent. ( CSP )] (UMLS (NCI) C0011041) =Organic Chemical; Hazardous or Poisonous Substance =chlorohydrocarbon insecticide;;
1,1,1 TRICHLOROETHANE: (UMLS (NDFRT)) (C0043697) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;; =Trichloroethanes;;Inactive Ingredient Preparations
1,1,1 TRICHLOROETHANE (INHIBITED) SOLN: [ ] (UMLS (RXNORM) C0973730) =Pharmacologic Substance
1,1,1-Trifluoro-2-bromo-2-chloroethane: [potent inhalation anesthetic widely used for induction and maintenance of general anesthesia. ( CSP )] (UMLS (NCI) C0018549) =Organic Chemical; Pharmacologic Substance =[CN200] ANESTHETICS;;Halogenated Hydrocarbon;;[CN201] ANESTHETICS INHALATION;;haloalkane =HALOTHANE 100 %
1,2,3-Trichloropropane: [A synthetic, colorless to light yellow liquid that is soluble in polar organic solvents and only slightly soluble in water. 1,2,3-Trichloropropane is used as both a chemical intermediate and cross-linking agent in the production of polymers. 1,2,3-Trichloropropane is flammable and, when heated to decomposition, emits toxic fumes of hydrogen chloride. Exposure of humans to 1,2,3-trichloropropane vapor causes irritation of the eyes and throat. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0043760) =Organic Chemical
1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl: [A synthetic triazine nucleoside derivative possessing antineoplastic and anti-psoriatic activity. After metabolism to 6-azauridine-5-prime monophosphate, 6-Azauridine inhibits de novo pyrimidine biosynthesis and incorporates the 5-prime triphosphate metabolite into RNA, thereby preventing nucleic acid synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0004483) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, Monohydrochloride: [The hydrochloride salt form of trazodone, a synthetic triazolopyridine derivative with antidepressant and sedative properties. Based on studies from animal models, trazodone selectively inhibits the re-uptake of serotonin by synaptosomes in the brain, thereby increasing serotonin levels in the synaptic cleft and potentiating serotonin activity. Trazodone is not a monoamine oxidase inhibitor and, unlike amphetamine-type drugs, does not stimulate the central nervous system. The sedative effect of trazodone is likely via alpha-adrenergic and mild histamine H1 blocking actions. ( NCI )] (UMLS (NCI) C0282369) =Organic Chemical; Pharmacologic Substance ;; =TRAZODONE;; =TRAZODONE HYDROCHLORIDE 150 MG;;TRAZODONE HYDROCHLORIDE 300 MG;;TRAZODONE HYDROCHLORIDE 50 MG;;TRAZODONE HYDROCHLORIDE 100 MG
1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-, monohydrochloride: [An alpha-1-adrenergic antagonist that acts by blocking alpha-adrenergic receptors in the smooth muscle of blood vessels (arteries, arterioles and veins), gastrointestinal tract, and radial smooth muscle of the iris. This prevents smooth muscle contraction and results in vasodilatation. Administered in the eye, dapiprazole hydrochloride produces miosis. In the heart, it may antagonize alpha-1 adrenoreceptors in myocytes causing a mild negative inotropic effect. ( NCI )] (UMLS (NCI) C0770916) Dapiprazole Hydrochloride;;DAPIPRAZOLE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =dapiprazole;; =DAPIPRAZOLE HYDROCHLORIDE 0.5 %;;
1,2,4-triglycidylurazol: [A synthetic triepoxide alkylating agent with cytostatic and immunosuppressant properties. Anaxirone alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA synthesis. This agent exhibits a broad spectrum of antineoplastic activity against experimental tumors, including those resistant to other alkylating agents. (NCI04) ( NCI )] (UMLS (NCI) C0043767) =Organic Chemical; Pharmacologic Substance ;;
1,3, 5-Triazin-2(1H)-one, 4-amino-1-.beta.-D- arabinofuranosyl- (9CI): [5 azacytosine arabinoside; USP lists as an antineoplastic agent. ( CSP )] (UMLS (NCI) C0060103) =Organic Chemical; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;;.beta.-Cytosine arabinoside;;nucleoside analog;;
1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride: (UMLS (NCI) C0952659) 5,6-dihydro-5-azacytidine HCl;;5,6-Dihydro-5-azacytidine hydrochloride =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
1,3,5-Triazine-2,4,6-triamine, N,N,N',N', N''-pentamethyl-, monohydrochloride (9CI): (UMLS (NCI) C0890530) Melamine, N2,N2,N4,N4,N6-pentamethyl-, monohydrochloride;;Pentamethylmelamine monoHCl;;Pentamethylmelamine monohydrochloride =Organic Chemical; Pharmacologic Substance
1,3,7-trimethylxanthine: [1,3,7-trimethylxanthine, a central nervous system stimulant; action may be mediated by adenosine receptors. ( CSP )] (UMLS (NCI) C0006644) =Organic Chemical; Pharmacologic Substance ;; =alkaloid;;[CN800] CNS STIMULANTS;;Xanthine Alkaloids;;xanthine;;methylpurine;;[CN809] CNS STIMULANTS, OTHER =Caffeina Citrata;;CAFFEINE 100 MG;;CAFFEINE 125 MG/ML;;CAFFEINE 30 MG;;CAFFEINE 32 MG;;CAFFEINE 40 MG;;CAFFEINE 65 MG;;CAFFEINE 200 MG;;CAFFEINE 20 MG/ML;;CAFFEINE 16 MG;;CAFFEINE 60 MG;;CAFFEINE 33 MG;;CAFFEINE 32.4 MG;;CAFFEINE 36 MG;;CAFFEINE 25 MG/5ML;;CAFFEINE 16.25 MG
1,3,8-Trihydroxy-6-methylanthraquinone: [Purgative anthraquinone found in several plants, especially Rhamnus frangula. It was formerly used as a laxative, but is now used mainly as tool in toxicity studies. ( MSH )] (UMLS (NCI) C0013982) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =Cascara;; =alloin;;
1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione: [A drug that blocks the effects of male hormones in the body. It belongs to the family of drugs called antiandrogens. ( NCI )] (UMLS (NCI) C0068771) =Organic Chemical; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;;imidazole;;[HS900] HORMONES/SYNTHETICS/MODIFIERS, OTHER;; =NILUTAMIDE 150 MG;;
2,2', 2''-Trichlorotriethylamine: [A nitrogen mustard vesicant that has application in chemical warfare, and has been used as a cytostatic alkylating agent in anti cancer therapy. ( NCI )] (UMLS (NCI) C0045236) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;;
2,4,5 trichlorophenoxyacetate: [ ] (UMLS (CSP) C0882610) =Organic Chemical; Hazardous or Poisonous Substance ;;
2,4,5-Trihydroxyphenethylamine: [neurotoxin used to induce experimental CNS and sympathetic neural lesions that model aging and various nervous disorders; also used to induce behavioral circling and as a potential antineoplastic for neuroblastoma. ( CSP )] (UMLS (NCI) C0085196) =Organic Chemical; Pharmacologic Substance =catecholamine;;Neurotoxin;;Dopamine Antagonist;;adrenergic antagonist
2,4,6-tribromophenol: (UMLS (NDFRT)) (C0045436) =Organic Chemical; Pharmacologic Substance ;; =phenol;; =BISMUTH TRIBROMOPHENATE
2,4,6-Trichlorophenol: [A synthetic, colorless crystalline solid that is slightly soluble in water and soluble in organic solvents. It has been used primarily in pesticide formulations and as a wood preservative, although most uses have been cancelled in the US. When heated to decomposition, 2,4,6-trichlorophenol emits toxic and corrosive fumes of hydrochloric acid and other toxic gases. Exposure of humans to 2,4,6-trichrophenol via inhalation has been reported to cause respiratory effects, altered pulmonary function and pulmonary lesions. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0045437) =Organic Chemical; Hazardous or Poisonous Substance ;;
2,4,6-Tris(dimethylamino)-s-triazine: [An anticancer drug that belongs to the family of drugs called alkylating agents. ( NCI )] (UMLS (NCI) C0019453) =Organic Chemical; Pharmacologic Substance ;; =[AN000] ANTINEOPLASTICS;;triazine =ALTRETAMINE 50 MG
2-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-as-triazine-3,5(2H,4H)-dione: [A drug used in the treatment of psoriasis. ( NCI )] (UMLS (NCI) C0052757) =Organic Chemical; Pharmacologic Substance
3,3',5-triiodo-L-thyronine: [one of the thyroid hormones; an organic iodine containing compound secreted in small amounts by the thyroid gland; most circulating triiodothyroinine is produced by the deiodination of thyroxine in the peripheral tissues. ( CSP )] (UMLS (NCI) C0041014) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =Thyroid Gland Hormone;;Thyronines;;3,3',5-triiodo-L-thyronine;;[HS851] THYROID SUPPLEMENTS =3,3',5-triiodo-L-thyronine;;LIOTHYRONINE SODIUM;;
3,4,4'-Trichlorodiphenylurea: [A triclosan analogue with an antibacterial property. Triclocarban exerts its effect by inhibiting the activity of enoyl-(acyl-carrier protein) (ACP) reductase, widely distributed in bacteria, fungi and plants. ACP reductase catalyses the last step in each cycle of fatty acid elongation in the type II fatty acid synthase systems. As a result, this agent interupts cell membrane synthesis and leads to bacterial growth inhibition. ( NCI )] (UMLS (NCI) C0077072) =Organic Chemical; Pharmacologic Substance
3,4,5-Trihydroxybenzoic Acid: (UMLS (NCI) C0885364) Gallic Acid =Organic Chemical ;;
3,6,4'-Trinitroflavone: (UMLS (NCI) C1883631) 3,6,4-Trinitroflavone;;3,6-Dinitro-2-(4-nitrophenyl)-4H-1-benzopyran-4-one;;R8153;; =Organic Chemical; Pharmacologic Substance
3-Tritylthio-L-Alanine: [A derivative of cysteine with antimitotic activity and potential antineoplastic activity. (NCI04) ( NCI )] (UMLS (NCI) C0601886) =Amino Acid, Peptide, or Protein ;;
4',5, 7-Trihydroxyisoflavone: [trihydroxyisoflavone; phytoestrogen found in soy based foods; may have cancer chemoprotective activity. ( CSP )] (UMLS (NCI) C0061202) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =flavone;;
4',5,7-Trihydroxy-6-methoxyisoflavone: [An isoflavone from Pueraria thunbergiana, which induces differentiation and apoptosis in cancer cells. (NCI) ( NCI )] (UMLS (NCI) C0769356) Tectorigenin =Organic Chemical
4,5-Trihydroxybenzylidene malononitrile: [A member of the tyrphostin family of tyrosine kinase inhibitors that competitively binds and inhibits epidermal growth factor receptor and GTPase activity of transducin and induces apoptosis in human leukemic cell lines. (NCI) ( NCI )] (UMLS (NCI) C0213654) =Organic Chemical; Pharmacologic Substance
TR: [A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. (NCI) ( NCI )] (UMLS (NCI) C0041400) =Geographic Area
TR 495: (UMLS (NCI) C1521777) TR-495;; =Organic Chemical; Pharmacologic Substance
Trabectedin: [A tetrahydroisoquinoline alkaloid isolated from the marine tunicate Ecteinascidia turbinate. Ecteinascidin 743 (ET743) exhibits potent tumor cytotoxicity by prolonging the G2-M phase of the cell cycle. This agent interacts with the transcription-coupled nucleotide excision repair machinery to induce lethal DNA strand breaks. (NCI04) ( NCI )] (UMLS (NCI) C1311070) =Organic Chemical; Pharmacologic Substance ;;
Trabecular Adenocarcinoma: [A malignant epithelial neoplasm characterized by the presence of a trabecular glandular architectural pattern. ( NCI )] (UMLS (NCI) C0302182) =Neoplastic Process
Trabecular Adenoma: [A benign epithelial neoplasm characterized by the presence of a trabecular glandular architectural pattern. ( NCI )] (UMLS (NCI) C0205651) =Neoplastic Process
trabecular meshwork: [trabeculum of loose fibers found at the iridocorneal angle between the anterior chamber of the eye and the venous sinus of the sclera; the aqueous humor filters through the spaces between the fibers into the sinus and passes into the bloodstream. ( CSP )] (UMLS (CSP) C0040573) =Body Part, Organ, or Organ Component ;; =sclera;;
Trabecular Pattern: (UMLS (NCI) C1336770) =Finding ;;
TRABECULECTOM AB EXTERNO: [Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculectomy, and laser perforation. ( MSH )] (UMLS (ICD9CM) C0040574) =Therapeutic or Preventive Procedure ;;
trabeculotomy: [creation of a fistula between the anterior chamber of the eye and the subconjunctival space by surgical removal of a portion of the trabecular meshwork, performed to facilitate drainage of the aqueous humor in glaucoma. ( CSP )] (UMLS (CSP) C0040576) =Therapeutic or Preventive Procedure ;; =glaucoma surgery;;
TRABECULOTOMY AB EXTERNO: [ ] (UMLS (ICD9CM) C0197534) =Therapeutic or Preventive Procedure
Trac Tabs 2x: [ ] (UMLS (RXNORM) C0723795) =Clinical Drug
trace: [The content is greater than zero, but too small to be quantified. ( HL7V3.0 )] (UMLS (HL7) C1552622) =Idea or Concept =unknown;;
TRACE: [LITERAL ( NCI )] (UMLS (NCI) C1705161) Trace Dosing Unit;; =Quantitative Concept
Trace Element Biochemistry: (UMLS (NCI) C1519570) =Biomedical Occupation or Discipline
Trace Element Nutrition, Fluorides: [Studies of the role of the trace element fluoride, obtained through diet, on general health ( NCI )] (UMLS (NCI) C1519571) =Research Activity
Trace Element Nutrition, Mercury: [Studies of the role of the trace element mercury, obtained through diet, on general health ( NCI )] (UMLS (NCI) C1519572) =Research Activity
Trace Element Nutrition, Other: (UMLS (NCI) C1519573) =Research Activity
TRACE ELEMENTS MIXED-5 INJ: (UMLS (NDFRT)) (C0980765) =Clinical Drug =chromic chloride 0.0205 MG/ML;;CUPRIC CHLORIDE 1.073 MG/ML;;MANGANESE CHLORIDE 0.36 MG/ML;;SELENIOUS ACID 32.67 MCG/ML;;ZINC CHLORIDE 2.085 MG/ML;;
trace elements with selenium 10 mcg-1 mg-0.5 mg-60 mcg-5 mg/ml intravenous solution: [ ] (UMLS (RXNORM) C1186998) =Clinical Drug
trace elements with selenium 2 mcg-0.2 mg-0.16 mg-0.8 mg/ml intravenous solution: [ ] (UMLS (RXNORM) C1168625) =Clinical Drug
trace elements with selenium 4 mcg-0.4 mcg-0.1 mg-20 mcg-1mg/mL intravenous solution: [ ] (UMLS (RXNORM) C1644784) =Clinical Drug
trace elements with selenium and iodide 4 mcg-0.4 mg-0.1 mg-20 mcg-25 mcg/ml intravenous solution: [ ] (UMLS (RXNORM) C0874238) trace elements with selenium and iodide 4 mcg-0.4 mg-0.1 mg-25 mcg-20 mcg/ml intravenous solution =Clinical Drug
Trace Metal Storage Protein: (UMLS (NCI) C1336771) =Amino Acid, Peptide, or Protein; Biologically Active Substance
TRACE METALS 100-1000 VIAL (SDV,MDV OR ADDITIVE) (ML): [ ] (UMLS (RXNORM) C1344260) TRACE METALS 100-1000 VIAL (SDV,MDV OR ADDITIVE) (ML);; =Clinical Drug
TRACE METALS ADDITIVE INJ: (UMLS (NDFRT)) (C0980766) =Clinical Drug =SODIUM CHLORIDE 9 MG;;CHROMIC CHLORIDE 6 MCG;;CHROMIUM (AS CHROMIC CHLORIDE) 10 MCG/5ML;;COPPER (AS CUPRIC CHLORIDE) 1 MG/5ML;;CUPRIC CHLORIDE 0.42 MG;;MANGANESE (AS CHLORIDE) 0.8 MG/5ML;;MANGANESE CHLORIDE 0.37 MG;;ZINC (AS CHLORIDE) 4 MG/5ML;;ZINC CHLORIDE 1.67 MG;;
TRACE METALS AMPUL (ML): [ ] (UMLS (RXNORM) C1341765) TRACE METALS AMPUL (ML);; =Clinical Drug
TRACE METALS CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1341314) TRACE METALS CAPSULE (HARD, SOFT, ETC.);; =Clinical Drug
TRACE METALS DISPOSABLE SYRINGE (ML): [ ] (UMLS (RXNORM) C1364295) =Clinical Drug
TRACE METALS PEDI-4 VIAL (SDV,MDV OR ADDITIVE) (ML): [ ] (UMLS (RXNORM) C1344259) TRACE METALS PEDI-4 VIAL (SDV,MDV OR ADDITIVE) (ML);; =Clinical Drug
TRACE METALS PEDI-5 VIAL (SDV,MDV OR ADDITIVE) (ML): [ ] (UMLS (RXNORM) C1344258) TRACE METALS PEDI-5 VIAL (SDV,MDV OR ADDITIVE) (ML);; =Clinical Drug
TRACE METALS VIAL (SDV,MDV OR ADDITIVE) (ML): [ ] (UMLS (RXNORM) C1364296) =Clinical Drug
TRACE METALS W-ELECTROLYTES AMPUL (ML): [ ] (UMLS (RXNORM) C1341764) TRACE METALS W-ELECTROLYTES AMPUL (ML);; =Clinical Drug
TRACE METALS W-ELECTROLYTES VIAL (SDV,MDV OR ADDITIVE) (ML): [ ] (UMLS (RXNORM) C0773092) TRACE METALS W-ELECTROLYTES INTRAVENOUS VIAL (SDV,MDV OR ADDITIVE) (ML);;TRACE METALS W-ELECTROLYTES VIAL (SDV,MDV OR ADDITIVE) (ML) =Clinical Drug
TRACE METALS/HERBAL DRUGS LIQUID (ML): [ ] (UMLS (RXNORM) C1352926) =Clinical Drug
TRACE METALS/MINERALS CAPSULE (HARD, SOFT, ETC.): [ ] (UMLS (RXNORM) C1339493) TRACE METALS/MINERALS CAPSULE (HARD, SOFT, ETC.) =Clinical Drug
Trace Min (Cr-Cu-F-FE-I-Mn-Mo-Se-Zn) Inj: [ ] (UMLS (RXNORM) C0793393) =Clinical Drug
Trace Min (Cr-Cu-I-Mn-Se-Zn) Inj .004-.4-.025-.1-.02-1 MG/ML: [ ] (UMLS (RXNORM) C0794164) =Clinical Drug
Trace Min (Cr-Cu-I-Mn-Se-Zn) Inj .01-1-.075-0.5-.06-5 MG/ML: [ ] (UMLS (RXNORM) C0784091) Trace Min (CrCuIMnSeZn) Inj 10-1000-75-500-60-5000 MCG/ML;; =Clinical Drug
Trace Min (Cr-Cu-Mn-Se-Zn) Inj 0.001-0.1-0.025-0.015-1 MG/ML: [ ] (UMLS (RXNORM) C0784087) Trace Min (Cr-Cu-Mn-Se-Zn) Inj 1-100-25-15-1000 MCG/ML;; =Clinical Drug
Trace Min (Cr-Cu-Mn-Se-Zn) Inj 0.004-0.4-0.1-0.02-1 MG/ML: [ ] (UMLS (RXNORM) C0784088) =Clinical Drug
Trace Min (Cr-Cu-Mn-Se-Zn) Inj 0.004-1-0.5-0.06-5 MG/ML: [ ] (UMLS (RXNORM) C0784089) =Clinical Drug
Trace Min (Cr-Cu-Mn-Se-Zn) Inj 0.01-1-0.5-0.06-5 MG/ML: [ ] (UMLS (RXNORM) C0784090) =Clinical Drug
Trace Min (Cr-Cu-Mn-Zn) Inj 0.001-0.1-0.025-1 MG/ML: [ ] (UMLS (RXNORM) C0784081) =Clinical Drug
Trace Min (Cr-Cu-Mn-Zn) Inj 0.001-0.1-0.03-0.5 MG/ML: [ ] (UMLS (RXNORM) C0784082) =Clinical Drug
Trace Min (Cr-Cu-Mn-Zn) Inj 0.002-0.2-0.16-0.8 MG/ML: [ ] (UMLS (RXNORM) C0784083) =Clinical Drug
Trace Min (Cr-Cu-Mn-Zn) Inj 0.004-0.4-0.1-1 MG/ML: [ ] (UMLS (RXNORM) C0784084) =Clinical Drug
Trace Min (Cr-Cu-Mn-Zn) Inj 0.01-1-0.5-4 MG/ML: [ ] (UMLS (RXNORM) C0784085) =Clinical Drug
Trace Min (CrCuIMnMoSeZn) Inj 4-400-25-100-25-20-1000 MCG/ML: [ ] (UMLS (RXNORM) C0784092) =Clinical Drug
Trace Minerals (Ca-Cu-Fe-I-K-Mg-Mn-P-Zn) Tab: [ ] (UMLS (RXNORM) C0784067) =Clinical Drug
TRACE-4 MULTIPLE TRACE ELEMENTS INJ: (UMLS (NDFRT)) (C0980767) =Clinical Drug =CHROMIC CHLORIDE 0.05 MG;;CUPRIC SULFATE 3.9 MG;;MANGANESE SULFATE 1.52 MG;;ZINC SULFATE 17.4 MG
TRACELYTE II (ELECTROLYTE TRACE ELEMENTS COMB) INJ: (UMLS (NDFRT)) (C0980768) =Clinical Drug =WATER FOR INJECTION [Ingredient];;ACETATE 1.48 MEQ/ML;;CALCIUM 0.225 MEQ/ML;;CHLORIDE 1.75 MEQ/ML;;CHROMIUM (AS CHROMIC CHLORIDE) 0.3 MCG/ML;;COPPER (AS CUPRIC SULFATE) 0.03 MG/ML;;MAGNESIUM 0.25 MEQ/ML;;MANGANESE (AS SULFATE) 0.007 MG/ML;;POTASSIUM 1 MEQ/ML;;SODIUM 1.75 MEQ/ML;;ZINC (AS SULFATE) 0.075 MG/ML;;
TRACELYTE II INJ: (UMLS (NDFRT)) (C0994623) =Clinical Drug =ACETATE 1.48 MEQ/ML;;CALCIUM 0.225 MEQ/ML;;CHLORIDE 1.75 MEQ/ML;;CHROMIUM (AS CHROMIC CHLORIDE) 0.6 MCG/ML;;COPPER (AS CUPRIC SULFATE) 0.06 MG/ML;;MAGNESIUM 0.25 MEQ/ML;;MANGANESE (AS SULFATE) 0.015 MG/ML;;POTASSIUM 1 MEQ/ML;;SODIUM 1.75 MEQ/ML;;ZINC (AS SULFATE) 0.15 MG/ML
TRACELYTE INJ: (UMLS (NDFRT)) (C0994618) =Clinical Drug =ACETATE 1.03 MEQ/ML;;CALCIUM 0.25 MEQ/ML;;CHLORIDE 1.765 MEQ/ML;;CHROMIUM (AS CHROMIC CHLORIDE) 0.6 MCG/ML;;COPPER (AS CUPRIC SULFATE) 0.06 MG/ML;;GLUCONATE 0.25 MEQ/ML;;MAGNESIUM 0.4 MEQ/ML;;MANGANESE (AS SULFATE) 0.015 MG/ML;;POTASSIUM 2.025 MEQ/ML;;SODIUM 1.25 MEQ/ML;;ZINC (AS SULFATE) 0.15 MG/ML;;
TRACELYTE W/DOUBLE ELECTROLYTES INJ: (UMLS (NDFRT)) (C0980771) =Clinical Drug =ACETATE 2 MEQ/ML;;CALCIUM 0.25 MEQ/ML;;CHLORIDE 1.68 MEQ/ML;;CHROMIUM (AS CHROMIC CHLORIDE) 0.3 MCG/ML;;COPPER (AS CUPRIC SULFATE) 0.03 MG/ML;;GLUCONATE 0.25 MEQ/ML;;MAGNESIUM 0.4 MEQ/ML;;MANGANESE (AS SULFATE) 0.007 MG/ML;;POTASSIUM 2 MEQ/ML;;SODIUM 1.25 MEQ/ML;;ZINC (AS SULFATE) 0.075 MG/ML;;
TRACER BG (GLUCOSE) TEST STRIP: (UMLS (NDFRT)) (C0980772) =Medical Device =GLUCOSE TEST PREPARATION;;
TRACER BG (TRACER II) TEST STRIP: (UMLS (NDFRT)) (C0980773) =Medical Device =GLUCOSE TEST PREPARATION;;
TRACER II BG (GLUCOSE) TEST KIT: (UMLS (NDFRT)) (C0980774) =Medical Device =GLUCOSE TEST PREPARATION;;
TRACH CARE TRAY KIT CAT NO W1102 COMBO: [ ] (UMLS (RXNORM) C1696320) =Medical Device ;;
trach tube: [(TRAY-kee-AHS-tuh-mee toob) A 2-inch- to 3-inch-long curved metal or plastic tube placed in a surgically created opening (tracheostomy) in the windpipe to keep it open. ( NCI )] (UMLS (NCI) C0184159) =Medical Device
trachea: [cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. ( CSP )] (UMLS (NCI) C0040578) =Body Part, Organ, or Organ Component ;; =Body System, Pulmonary;;Body Part
Trachea (MMHCC): (UMLS (NCI) C1519575) =Tissue
Trachea Basal Lamina: (UMLS (NCI) C1710454) =Tissue ;;
Trachea Basement Membrane: (UMLS (NCI) C1710455) =Tissue ;;
Trachea Cartilage: (UMLS (NCI) C1710456) =Body Part, Organ, or Organ Component ;;
Trachea fistula: (UMLS (NCI) C1963251) Trachea Fistula Adverse Event;; =Finding
Trachea hemorrhage: (UMLS (NCI) C1556636) Trachea Hemorrhage Adverse Event;; =Finding
Trachea infection (documented clinically or microbiologically) with Grade 3 or 4 neutrophils (ANC: (UMLS (NCI) C1560885) Trachea Infection Adverse Event Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils;; =Finding
Trachea Infection Adverse Event with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils: (UMLS (NCI) C1559808) Trachea infection with normal ANC or Grade 1 or 2 neutrophils;; =Disease or Syndrome
Trachea Infection Adverse Event with Unknown Absolute Neutrophil Count: (UMLS (NCI) C1557049) Trachea infection with unknown ANC;; =Finding
Trachea intra-operative injury: (UMLS (NCI) C1558811) Trachea Intra-Operative Injury Adverse Event;; =Injury or Poisoning

UMLS

1 2 3 4 .. 33 Next >>

MEDINDEX.AM

to main page

About • Catalog. Medical sites. • UMLS.Semantic Types. • Feedback

top of page